At close: December 20 at 4:00:03 PM EST
After hours: 7:22:38 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 1 | 3 | 3 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | 260.5k | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | -100.00% | 0.00% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.85 | -0.79 | -0.67 | -0.48 |
| EPS Actual | -0.64 | -0.73 | -0.66 | -0.65 |
| Difference | 0.21 | 0.06 | 0.01 | -0.17 |
| Surprise % | 24.71% | 7.59% | 1.49% | -35.42% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| IKT | -- | -- | -- | -- |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Upgrades & Downgrades
| Initiated | Jefferies: Buy | 11/8/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 10/14/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 8/16/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 5/21/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/7/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/5/2024 |
Related Tickers
RAPP Rapport Therapeutics, Inc.
18.07
+1.18%
XLO Xilio Therapeutics, Inc.
1.2800
+36.46%
LPCN Lipocine Inc.
4.8700
+4.06%
TRVI Trevi Therapeutics, Inc.
4.0500
-2.41%
ANVS Annovis Bio, Inc.
4.3700
-0.68%
LRMR Larimar Therapeutics, Inc.
4.0100
+0.75%
MCRB Seres Therapeutics, Inc.
0.9155
-0.59%
SLNO Soleno Therapeutics, Inc.
45.18
-0.04%
PRLD Prelude Therapeutics Incorporated
1.3000
+46.40%
MIST Milestone Pharmaceuticals Inc.
1.8000
+4.96%